NIH has announced the launch of the 2018-2019 Niche Assessment Program available to HHS (NIH, CDC, FDA) SBIR and STTR Phase I awardees and Phase I Fast-Track awardees (by grant or contract). Though the Niche Assessment program, Foresight Science & Technology provides an unbiased third-party assessment of appropriate market niches for products/services that are being developed by HHS SBIR/STTR Phase I awardees on behalf of NIH. Using its Technology Niche Analysis® (TNA®), Foresight will perform the due diligence on markets appropriate for each SBIR technology and develop an in-depth report for each SBIR/STTR awardee that addresses:
- needs and concerns of end-users
- competing technologies and competing products
- competitive advantage of the SBIR/STTR-developed technology
- market size and potential market share (may include national and/or global markets)
- barriers to market entry (may include, but is not limited to pricing, competition, government regulations, manufacturing challenges, capital requirements, etc.)
- market drivers
- status of market and industry trends
- potential customers, licensees, investors, or other commercialization partners
- price customers are likely to pay
There are 200 slots for the Niche Assessment Program this year!
Learn more here: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-012.html